Essential oils purified from Schisandrae semen inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 activation and migration of human aortic smooth muscle cells

BMC Complement Altern Med. 2015 Feb 5:15:7. doi: 10.1186/s12906-015-0523-9.

Abstract

Background: The migration of vascular smooth muscle cells from the tunica media to the subendothelial region may be a key event in the development of atherosclerosis after arterial injury. In this study, we investigated the potential mechanisms underlying the anti-atherosclerotic effects of Schisandrae Semen essential oil (SSeo) in human aortic smooth muscle cells (HASMCs).

Methods: Metalloproteinase-2/9 (MMP-2/9) activity was evaluated by gelatin zymography and gelatinase activity assay kit. The possible mechanisms underlying SSeo-mediated reduction of by tumor necrosis factor (TNF)-α-induced cell invasion and inhibition of secreted and cytosolic MMP-9 production in HASMCs were investigated.

Results: Our results indicate that SSeo treatment has an inhibitory effect on activation as well as expression of MMP-9 induced by TNF-α in HASMCs in a dose-dependent manner without significant cytotoxicity. SSeo attenuated nuclear translocation of TNF-α-mediated nuclear factor-kappa B (NF-κB) and blocked degradation of the NF-κB inhibitor proteins as well as the production of reactive oxygen species. SSeo also reduced TNF-α-induced production of pro-inflammatory mediators such as nitric oxide and prostaglandin E2 and inhibited inducible nitric oxide synthase and cyclooxygenase-2 expression in HASMCs. Furthermore, the Matrigel migration assay showed that SSeo effectively reduced TNF-α-induced HASMC migration compared with that in the control group.

Conclusions: Taken together, these results suggest that SSeo treatment suppresses TNF-α-induced HASMC migration by selectively inhibiting MMP-9 expression, which was associated with suppression of the NF-κB signaling pathway. Taken together, these results suggest that SSeo has putative potential anti-atherosclerotic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aorta / drug effects
  • Aorta / metabolism
  • Atherosclerosis / metabolism*
  • Atherosclerosis / prevention & control
  • Cell Movement / drug effects*
  • Cyclooxygenase 2 / metabolism
  • Humans
  • Matrix Metalloproteinase 9 / metabolism*
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Myocytes, Smooth Muscle / drug effects
  • NF-kappa B / metabolism
  • Oils, Volatile / isolation & purification
  • Oils, Volatile / pharmacology*
  • Oils, Volatile / therapeutic use
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Schisandra / chemistry*
  • Seeds / chemistry
  • Signal Transduction / drug effects
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • NF-kappa B
  • Oils, Volatile
  • Plant Extracts
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Cyclooxygenase 2
  • Matrix Metalloproteinase 9